Revolution Medicines, Inc. (NASDAQ:RVMDW) Sees Significant Growth in Short Interest

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 500 shares, an increase of 25.0% from the November 15th total of 400 shares. Based on an average daily trading volume, of 36,800 shares, the days-to-cover ratio is currently 0.0 days.

Revolution Medicines Stock Up 8.6 %

Shares of NASDAQ RVMDW traded up $0.03 during midday trading on Monday, reaching $0.34. 1,685 shares of the stock traded hands, compared to its average volume of 17,934. Revolution Medicines has a one year low of $0.05 and a one year high of $0.80. The company’s 50 day moving average is $0.32 and its 200 day moving average is $0.20.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.